Technical Analysis for XOMAP - XOMA Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 26.01 | 1.90% | 0.49 |
XOMAP closed up 1.9 percent on Monday, July 1, 2024, on 2.62 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gilligan's Island Sell Setup | Bearish Swing Setup | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% |
| Alert | Time |
|---|---|
| Gapped Up (Full) | about 11 hours ago |
| Rose Above Previous Day's High | about 11 hours ago |
| New 52 Week High | about 11 hours ago |
| Rose Above Upper Bollinger Band | about 11 hours ago |
| 2x Volume Pace | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/06/2024
XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
Keywords: Biotechnology
Classification
Keywords: Biotechnology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.479 |
| 52 Week Low | 20.502 |
| Average Volume | 1,469 |
| 200-Day Moving Average | 23.79 |
| 50-Day Moving Average | 25.19 |
| 20-Day Moving Average | 25.38 |
| 10-Day Moving Average | 25.46 |
| Average True Range | 0.20 |
| RSI (14) | 68.65 |
| ADX | 22.42 |
| +DI | 61.55 |
| -DI | 21.21 |
| Chandelier Exit (Long, 3 ATRs) | 25.88 |
| Chandelier Exit (Short, 3 ATRs) | 25.57 |
| Upper Bollinger Bands | 25.82 |
| Lower Bollinger Band | 24.94 |
| Percent B (%b) | 1.2 |
| BandWidth | 3.47 |
| MACD Line | 0.13 |
| MACD Signal Line | 0.10 |
| MACD Histogram | 0.0321 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 27.40 | ||||
| Resistance 3 (R3) | 27.40 | 26.94 | 27.17 | ||
| Resistance 2 (R2) | 26.94 | 26.59 | 26.94 | 27.09 | |
| Resistance 1 (R1) | 26.47 | 26.37 | 26.24 | 26.47 | 27.01 |
| Pivot Point | 26.01 | 26.01 | 25.90 | 26.01 | 26.01 |
| Support 1 (S1) | 25.54 | 25.66 | 25.31 | 25.54 | 25.00 |
| Support 2 (S2) | 25.08 | 25.44 | 25.08 | 24.92 | |
| Support 3 (S3) | 24.61 | 25.08 | 24.84 | ||
| Support 4 (S4) | 24.61 |
